Brief: Fulcrum Therapeutics Inc Myokardia Terminates Collaboration And License Agreement With Co
04/03/2025 22:04
March 4 (Reuters) - Fulcrum Therapeutics Inc FULC.O: FULCRUM THERAPEUTICS INC - MYOKARDIA TERMINATES COLLABORATION AND LICENSE AGREEMENT WITH CO FULCRUM THERAPEUTICS INC - TERMINATION EFFECTIVE JUNE 26, 2025 Further company coverage: FULC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program